Rockwell Medical is a biopharmaceutical company. Co. also manufactures, sells and delivers hemodialysis concentrates, which are used to maintain human life by removing toxins and balancing electrolytes in the dialysis patient's bloodstream. Co.'s two products from its Ferric Pyrophosphate Citrate (FPC) platform, Triferic® (dialysate) and Triferic AVNU® (IV), are used to maintain hemoglobin in patients undergoing hemodialysis. Co. is engaging in a clinical trial program of FPC for the treatment of iron deficiency anemia in the home-infusion setting. Co. is also investigating the use of its FPC platform for the treatment of hospitalized patients with acute heart failure. The RMTI stock yearly return is shown above.
The yearly return on the RMTI stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2021 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the RMTI annual return calculation with any dividends reinvested as applicable (on ex-dates).
|